Marex Group’s IDEAYA Biosciences IDYA Stock Holding History

Marex Group’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$607K	Buy	16,283 +1,782	+12%	+$54.5K	﹤0.01%	638
2026 Q1	$483K	Buy	+14,501	New	+$486K	﹤0.01%	627

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Marex Group's IDYA Position: Q2 2026 in Review

Marex Group increased its IDEAYA Biosciences (IDYA) stake by 12% in Q2 2026, buying an estimated $54.5K and bringing the position to 16,283 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #638.

Marex Group first reported a position in IDYA in Q1 2026 and has held it in 2 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Marex Group held 16,283 shares of IDEAYA Biosciences worth $607K as of Q2 2026.
Marex Group bought 1,782 IDEAYA Biosciences shares in Q2 2026, an estimated $54.5K.
IDEAYA Biosciences made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #638 holding.
Marex Group first reported a position in IDEAYA Biosciences in Q1 2026 and has held it in 2 quarters since.
284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.